Market Overview The global Neoantigen & Personalized Cancer Vaccines Market is gaining momentum as advances in precision oncology enable the development of cancer vaccines tailored to the genetic characteristics of individual tumors. One published estimate values the broader personalized cancer vaccine market at USD 0.6 billion in 2025, with a projection of USD 5.5 billion by 2035,...